Search Keyword:


Search option:


IID01026
UniprotQ9P278
ProteinFolliculin-interacting protein 2
GeneFNIP2
OrganismHomo sapiens
Sequence LLPS PhaSepDB
PhaSePro
LLPSDB
DrLLPS
xml rdf
Structure
Experiment
  :order   disorder   conflict   PDB cluster   ProS   Pfam Domain   SEG
1114
 order/disorder by at least rule
     disorder by at least rule
     order by at least rule
 order/disorder by majority rule
Seq 552-576 Hetero dodecamer : IID00921Complex
 Evidence X-RAY 7lsw A Reference
       Region 7lsw A 552-576 order
 Evidence X-RAY 7lsw B Reference
       Region 7lsw B 552-576 order
 Evidence X-RAY 7lsw C Reference
       Region 7lsw C 552-576 order
 Evidence X-RAY 7lsw D Reference
       Region 7lsw D 552-576 order
 Evidence X-RAY 7lsw E Reference
       Region 7lsw E 552-575 order
       Region 7lsw E 576-576 disorder
 Evidence X-RAY 7lsw F Reference
       Region 7lsw F 552-574 order
       Region 7lsw F 575-576 disorder
Seq 558-576 Hetero hexamer : IID00921Complex
 Evidence X-RAY 7lt6 A Reference
       Region 7lt6 A 558-576 order
 Evidence X-RAY 7lt6 B Reference
       Region 7lt6 B 558-559 order
       Region 7lt6 B 560-561 disorder
       Region 7lt6 B 562-573 order
       Region 7lt6 B 574-576 disorder
 Evidence X-RAY 7lt6 C Reference
       Region 7lt6 C 558-560 order
       Region 7lt6 C 561-562 disorder
       Region 7lt6 C 563-576 order
SeqProS predicted 552-576 This region is predicted to be disordered by NeProc and AlphaFold (pLDDT < 68.5). Hetero dodecamer : IID00921Complex
       Region 7lsw A 552-576 order
       Region 7lsw B 552-576 order
       Region 7lsw C 552-576 order
       Region 7lsw D 552-576 order
       Region 7lsw E 552-575 order
       Region 7lsw F 552-574 order
SeqProS predicted 552-576 This region is predicted to be disordered by NeProc and AlphaFold (pLDDT < 68.5). Hetero hexamer : IID00921Complex
       Region 7lt6 A 558-576 order
       Region 7lt6 B 558-559 order
       Region 7lt6 B 562-573 order
       Region 7lt6 C 558-560 order
       Region 7lt6 C 563-576 order
Seqphosphorylation
    723-723 Phosphoserine
    221-221 Phosphoserine
    216-216 Phosphoserine
    726-726 Phosphoserine
 
Prediction
NeProc
Disorder 1-33,73-133,153-307,543-929
Order 34-72,134-152,308-321,326-542,930-1114
ProS 1-33,89-96,119-133,153-176,184-252,263-307,543-577,590-603,614-618,639-656,665-669,692-750,756-812,839-913,918-929
AlphaFold
Disorder 1-43,56-58,73-124,146-153,174-188,190-308,406-408,455-481,533-551,556-567,573-941,1014-1016,1018-1018,1111-1114
Order 44-55,59-72,125-145,154-173,189-189,309-405,409-454,482-532,552-555,568-572,942-1013,1017-1017,1019-1110
SEG 13-28 ,94-118 ,244-265 ,819-840 ,1025-1041
Function
Function in SwissProt
Binding partner of the GTPase-activating protein FLCN: involved in the cellular response to amino acid availability by regulating the non-canonical mTORC1 signaling cascade controlling the MiT/TFE factors TFEB and TFE3 (PubMed:18663353, PubMed:31672913, PubMed:36103527). Required to promote FLCN recruitment to lysosomes and interaction with Rag GTPases, leading to activation of the non-canonical mTORC1 signaling (By similarity). In low-amino acid conditions, component of the lysosomal folliculin complex (LFC) on the membrane of lysosomes, which inhibits the GTPase-activating activity of FLCN, thereby inactivating mTORC1 and promoting nuclear translocation of TFEB and TFE3 (PubMed:31672913, PubMed:36103527). Upon amino acid restimulation, disassembly of the LFC complex liberates the GTPase-activating activity of FLCN, leading to activation of mTORC1 and subsequent inactivation of TFEB and TFE3 (PubMed:31672913). Together with FLCN, regulates autophagy: following phosphorylation by ULK1, interacts with GABARAP and promotes autophagy (PubMed:25126726). In addition to its role in mTORC1 signaling, also acts as a co-chaperone of HSP90AA1/Hsp90: inhibits the ATPase activity of HSP90AA1/Hsp90, leading to activate both kinase and non-kinase client proteins of HSP90AA1/Hsp90 (PubMed:18403135). Acts as a scaffold to load client protein FLCN onto HSP90AA1/Hsp90 (PubMed:18403135). Competes with the activating co-chaperone AHSA1 for binding to HSP90AA1, thereby providing a reciprocal regulatory mechanism for chaperoning of client proteins (PubMed:18403135). May play a role in the signal transduction pathway of apoptosis induced by O6-methylguanine-mispaired lesions (By similarity).